US FDA User Fees: Lay-Off Notices Planned For Early September If Congress Doesn’t Pass Bill

 
• By Derrick Gingery
  
Ticking clock and negotiating table
Stakeholders are waiting for legislators to return to the negotiating table and complete the FDA user fee reauthorization bill. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from User Fees

More from Pathways & Standards